The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC157, TB500, GHK Cu FDA Gray Market Peptides: So Much Hype, So Little Data Is the lack of human data in BPC 157 a red flag? If a drug could actually knit torn tendons back together in weeks, a trillion dollar pharmaceutical industry probably wouldn't bury FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law